| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.07B | -7.3% |
| Cost of Revenue | $7.83B | -6.7% |
| R&D Expense | $508.0M | -5.2% |
| SG&A Expense | $1.41B | -4.0% |
| Interest Expense | $396.0M | -19.5% |
| Pre-tax Income | $504.0M | -65.2% |
| Income Tax | -$29.0M | -107.5% |
| Net Income | $423.0M | -92.8% |
| EPS (Basic) | $0.94 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.39B | -34.7% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $1.51B | -3.4% |
| Inventory | $2.15B | -7.8% |
| Current Assets | $7.51B | -33.3% |
| Total Assets | $38.55B | -6.8% |
| Current Liabilities | $3.10B | -17.0% |
| -92.0% |
| EPS (Diluted) | $0.94 | -92.0% |
| Long-term Debt |
| $7.86B |
| -3.5% |
| Total Liabilities | $13.83B | -3.6% |
| Stockholders' Equity | $24.28B | -8.6% |